Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Cell Free Tumor DNA for DLBCL Genotyping in a Phase II Randomized Trial Comparing Standard RCHOP Versus Brcap As First Line Treatment in Patients with Poor IPI DLBCL

Nerea Martinez, PhD, Sonia González de Villambrosia, MD, Ainara Pereña, Raul Tonda, Sergi Beltran, PhD, Marta Gut, PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD, Alejandro Martín, MD, Concepcion Nicolas, MD, Jose Maria Roncero, MD, Maria J. Rodriguez-Salazar, MD, Jaime Perez De Oteyza, MDPhD, Eulogio Conde, MD PhD, Eva Gonzalez-Barca, Santiago Montes-Moreno, MD PhD

Blood (2018) 132 (Supplement 1): 1676.

https://doi.org/10.1182/blood-2018-99-113757

Published: 2018

Journal Articles

Elevated FANCA Expression Marks a Worse Prognosis in Chronic Lymphocytic Leukemia. Evidence of a New Role of FANCA in the Stability of p53 By a Neddylation-Related Mechanism

Carlos Pipaon, PhD, Sara Bravo Navas, Iñigo Romon, MD PhD, Eulogio Conde, MD PhD, Lucrecia Yanez San Segundo, MD PhD

Blood (2018) 132 (Supplement 1): 5541.

https://doi.org/10.1182/blood-2018-99-113398

Published: 2018

Journal Articles

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Cristina Fernández Martínez, Arancha Bermúdez, MD, Sara García Ávila, MD, Borja San Pedro, Almudena Cabero Martínez, MD, Lucrecia Yáñez, MD PhD, Mónica López Duarte, Mercedes Colorado, MD, Sonia González de Villambrosia, MD, Joan Manuel Mora, MD, Yolanda Gonzalez Romero, MD, David Gomez, MD, Sara Fenandez Luis, MD, Irati Ormazabal, MD, Andrés Insunza, Iñigo Romon, MD PhD, Jose Luis Arroyo, MD, Eulogio Conde, MD PhD, Carlos Richard, MD

Blood (2018) 132 (Supplement 1): 5716.

https://doi.org/10.1182/blood-2018-99-114124

Published: 2018

Journal Articles

Very Low Dose of Anti-T-Lymphocyte Globulin Protects Against Severe Forms of Graft Versus Host Disease in High Risk Patients: The Experience in Our Center

Joan Manuel Mora, MD, Arancha Bermúdez, MD, Miguel Angel Cortés, MD, Yolanda González Romero, MD, Mercedes Colorado, MD, Cristina Fernández Martínez, MD, Almudena Cabero Martínez, MD, David Gómez, MD, Sara Fernández Luis, MD, Sara García Ávila, MD, Lucrecia Yáñez, MD PhD, Irati Ormazabal, MD, Guillermo Martín Sánchez, MD, Jose Luis Arroyo, MD, Javier Núñez, MD, Iñigo Romón, MD PhD, Eulogio Conde, MD PhD, Carlos Richard, MD

Blood (2018) 132 (Supplement 1): 5723.

https://doi.org/10.1182/blood-2018-99-118664

Published: 2018

Journal Articles

Long-Term Results and Cost-Effectiveness of the Flagida-Lite Regimen in Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Almudena Cabero Martínez, Arancha Bermudez, Lucrecia Yañez, Andrés Insunza, Mercedes Araujo Colorado, PhD, Cristina Fernandez Martinez, Virginia Martinez Callejo, Teresa Bernal Del Castillo, MD PhD, Miriam Sánchez Escamilla, Mónica López Duarte, German Pérez Vázquez, Carmen Montes, Eulogio Conde, MD PhD, Maria Luisa Gutiérrez, Sara García Ávila, Mara Celis, Carlos Richard

Blood (2017) 130 (Supplement 1): 2614.

https://doi.org/10.1182/blood.V130.Suppl_1.2614.2614

Published: 2017

Journal Articles

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Guillermo Martín-Sánchez, MD, Cristina Amunarriz, MD, Miriam Sanchez, Maria Aranzazu Bermudez, MD, Lucrecia Yañez, MD PhD, Mercedes Colorado, MD, Carlos Richard, MD, Eulogio Conde, MD PhD, Jose Luis Arroyo, MD PhD

Blood (2016) 128 (22): 5737.

https://doi.org/10.1182/blood.V128.22.5737.5737

Published: 2016

Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Blood (2016) 128 (22): 4201.

https://doi.org/10.1182/blood.V128.22.4201.4201

Published: 2016

Journal Articles

B Cell Lymphoma Unclassifiable, with Features Intermediate Between Diffuse Large B Cell Lymphoma and Burkitt Lymphoma and Diffuse Large B Cell Lymphoma NOS with Doble/Triple Translocations: Immunophenotypic Analysis

Sonia González de Villambrosia, Mercedes Colorado, Andres Insunza, Ana Batlle, Brenda López-Pereira, Guillermo Martin, Paloma Ibarrondo, Santiago Montes-Moreno, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5037.

https://doi.org/10.1182/blood.V126.23.5037.5037

Published: 2015

Journal Articles

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

Irati Ormazabal Velez, Maria Aranzazu Bermudez, MD, Andres Insunza, Lucrecia Yañez, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5468.

https://doi.org/10.1182/blood.V126.23.5468.5468

Published: 2015

Journal Articles

Differences of Antithymocyte Globulin (ATG) Side Effects during Allogeneic Stem Cell Transplantation

Lucrecia Yañez San Segundo, MD PhD, Brenda Lopez Pereira, MD, Maria Aranzazu Bermudez, MD, Andres Insunza, Iñigo Romon, MD PhD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5449.

https://doi.org/10.1182/blood.V126.23.5449.5449

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Blood (2014) 124 (21): 3980.

https://doi.org/10.1182/blood.V124.21.3980.3980

Published: 2014

Journal Articles

Impact of Neurological Complications on the Overall Survival in Allogeneic Stem Cell Transplantation

Paloma Ibarrondo, Arancha Bermudez, MD, Irati Ormazabal, Lucrecia Yáñez, MD, Carmen Montes-Gaisán, MD, Carlos De Miguel, Carlos Richard, MD, Andrés Insunza, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 3894.

https://doi.org/10.1182/blood.V124.21.3894.3894

Published: 2014

Journal Articles

Survival Outcome and Long-Term Follow-up of Autologous and Allogeneic Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML): A 30 Years Single-Center Experience

Carmen Montes-Gaisán, MD, German Perez, MD, Arancha Bermudez, MD, Amalia Cuesta, MD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 5890.

https://doi.org/10.1182/blood.V124.21.5890.5890

Published: 2014

Journal Articles

A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis

Blood (2014) 124 (21): 2524.

https://doi.org/10.1182/blood.V124.21.2524.2524

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party

Irit Avivi, MD, Ariane Boumendil, Hervé Hervé Finel, PhD, Arnon Nagler, MD, Aïda Sousa Bothello, MD, Josep Maria Ribera Santasusana, MD, Elisabeth A. Vandenberghe, MB, PhD, Boris Afanasyev, Dominique Bordessoule, MD, José Maria Moraleda, MD, Eulogio Conde, MD PhD, David Pohlreich, Peter Dreger, MD

Blood (2014) 124 (21): 1195.

https://doi.org/10.1182/blood.V124.21.1195.1195

Published: 2014

Journal Articles

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Lucrecia Yáñez, MD, Noemí Fernández, MD, Arancha Bermudez, MD, Germán Pérez, MD, Andres Insunza, MD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 1154.

https://doi.org/10.1182/blood.V124.21.1154.1154

Published: 2014

Journal Articles

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

Lucrecia Yanez, MD, Brenda López Pereira, Arancha Bermudez, MD, Andres Insunza, MD, Carlos Richard, MD, Mario Gonzalez Ruiz, M.D, Esmeralda Cuaresma, MD, Eulogio Conde, MD, PhD

Blood (2013) 122 (21): 5451.

https://doi.org/10.1182/blood.V122.21.5451.5451

Published: 2013

Journal Articles

Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase( CML-CP) Patients Treated Upfront With Nilotinib. The Spanish Substudy Of The ENEST1st Trial

Blood (2013) 122 (21): 5190.

https://doi.org/10.1182/blood.V122.21.5190.5190

Published: 2013

Journal Articles

Outcome Depend On Age But Not Comorbidity Score, In Patients treated With Fludarabine and Busulfan (FB4) As Conditioning Regimen In Allogeneic Stem Cell Transplantation

Javier Nunez, MD, Arancha Bermudez, MD, Lucrecia Yanez, MD, Guillermo Martin, MD, Andres Insunza, MD, Carlos Richard, MD, Carmen Montes Gaisan, MD, Eulogio Conde, MD, PhD

Blood (2013) 122 (21): 4533.

https://doi.org/10.1182/blood.V122.21.4533.4533

Published: 2013

Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Blood (2013) 122 (21): 369.

https://doi.org/10.1182/blood.V122.21.369.369

Published: 2013

NARROW

Cell Free Tumor DNA for DLBCL Genotyping in a Phase II Randomized Trial Comparing Standard RCHOP Versus Brcap As First Line Treatment in Patients with Poor IPI DLBCL

Elevated FANCA Expression Marks a Worse Prognosis in Chronic Lymphocytic Leukemia. Evidence of a New Role of FANCA in the Stability of p53 By a Neddylation-Related Mechanism

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Very Low Dose of Anti-T-Lymphocyte Globulin Protects Against Severe Forms of Graft Versus Host Disease in High Risk Patients: The Experience in Our Center

Long-Term Results and Cost-Effectiveness of the Flagida-Lite Regimen in Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

B Cell Lymphoma Unclassifiable, with Features Intermediate Between Diffuse Large B Cell Lymphoma and Burkitt Lymphoma and Diffuse Large B Cell Lymphoma NOS with Doble/Triple Translocations: Immunophenotypic Analysis

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

Differences of Antithymocyte Globulin (ATG) Side Effects during Allogeneic Stem Cell Transplantation

Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma: A Retrospective Study of the Geltamo Group (1994-2011)

Impact of Neurological Complications on the Overall Survival in Allogeneic Stem Cell Transplantation

Survival Outcome and Long-Term Follow-up of Autologous and Allogeneic Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML): A 30 Years Single-Center Experience

A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis

Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase( CML-CP) Patients Treated Upfront With Nilotinib. The Spanish Substudy Of The ENEST1st Trial

Outcome Depend On Age But Not Comorbidity Score, In Patients treated With Fludarabine and Busulfan (FB4) As Conditioning Regimen In Allogeneic Stem Cell Transplantation

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only